Related Experiment Video
Updated: Jun 25, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
TGF-beta signal transduction in chronic kidney disease
H William Schnaper1, Sara Jandeska, Constance E Runyan
1Division of Kidney Diseases, Department of Pediatrics, Northwestern University Feinberg School of Medicine, 303 E Chicago Ave.; Chicago, IL 60611-3008, USA. Schnaper@northwestern.edu
Abstract:
Transforming growth factor (TGF)-beta is a central stimulus of the events leading to chronic progressive kidney disease, having been implicated in the regulation of cell proliferation, hypertrophy, apoptosis and fibrogenesis. The fact that it mediates these varied events suggests that multiple mechanisms play a role in determining the outcome of TGF-beta signaling. Regulation begins with the availability and activation of TGF-beta and continues through receptor expression and localization, control of the TGF-beta family-specific Smad signaling proteins, and interaction of the Smads with multiple signaling pathways extending into the nucleus. Studies of these mechanisms in kidney cells and in whole-animal experimental models, reviewed here, are beginning to provide insight into the role of TGF-beta in the pathogenesis of renal dysfunction and its potential treatment.
Insights
Transforming growth factor-beta (TGF-beta) drives chronic kidney disease through complex signaling pathways. Understanding these mechanisms offers potential therapeutic targets for renal dysfunction.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Signaling
Background:
- Transforming growth factor-beta (TGF-beta) is a key mediator in chronic progressive kidney disease.
- TGF-beta influences critical cellular processes including proliferation, hypertrophy, apoptosis, and fibrogenesis.
- The diverse effects of TGF-beta suggest intricate regulatory mechanisms governing its signaling.
Purpose of the Study:
- To review the multifaceted mechanisms regulating TGF-beta signaling in the kidney.
- To elucidate the role of TGF-beta in the pathogenesis of renal dysfunction.
- To explore potential therapeutic strategies targeting TGF-beta pathways.
Main Methods:
- Review of studies on TGF-beta signaling pathways in kidney cells.
- Analysis of findings from whole-animal experimental models of kidney disease.
- Examination of regulatory steps from TGF-beta availability to nuclear signaling.
Main Results:
- TGF-beta signaling is tightly regulated at multiple levels, including ligand availability, receptor interactions, and Smad protein activity.
- Dysregulation of TGF-beta signaling contributes significantly to kidney disease progression.
- Interactions between Smad proteins and other signaling pathways are crucial for nuclear responses.
Conclusions:
- TGF-beta signaling is a central driver of chronic kidney disease pathogenesis.
- Targeting specific components of the TGF-beta pathway holds promise for treating renal dysfunction.
- Further research into these complex mechanisms is essential for developing effective therapies.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
TGF - β Signaling Pathway
Acute Kidney Injury II: Pathophysiology
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
